INTC
49
-3
PM
52
2
MRK
45
2
STZ
47
2
ESS
42
6
STT
50
5
L
51
2
WHR
57
-5
DE
56
3
EW
44
-4
O
35
2
GPC
56
2
HRL
33
3
HUM
43
2
BMY
37
2
IP
64
2
EXR
37
6
JNJ
54
10
BSX
63
-3
ECL
59
5
INTC
49
-3
PM
52
2
MRK
45
2
STZ
47
2
ESS
42
6
STT
50
5
L
51
2
WHR
57
-5
DE
56
3
EW
44
-4
O
35
2
GPC
56
2
HRL
33
3
HUM
43
2
BMY
37
2
IP
64
2
EXR
37
6
JNJ
54
10
BSX
63
-3
ECL
59
5
Financhill
Back

Fiskars Oyj 10K Form

Buy
60

FKRAF
Fiskars Oyj

Last Price:
$16.50
Seasonality Move:
0.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FKRAF News And Ratings

See the #1 stock for the next 7 days that we like better than FKRAF

FKRAF Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $-19.5M
Price / Cash Flow: 18.87
Annual Sales: $9.45
Price / Book: 1.74

Profitability

EPS (TTM): 0.14820
Net Income (TTM): $12.2M
Gross Margin: $559.6M
Return on Equity: 1.5%
Return on Assets: 0.67%

Fiskars Oyj Earnings Forecast

Key Fiskars Oyj Financial Ratios

  • The Gross Profit Margin over the past 28 years for FKRAF is 44.68%.
  • The Selling, General & Administrative Expenses for FKRAF have been equal to 39.45% of Gross Profit Margin.
  • The Research & Development expenses have been 1.62% of Revenue.
  • The Interest Expense is 116.24% of Operating Income.
  • The Net Earning history of FKRAF is 2.34% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 15 years.

Fiskars Oyj Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Household Durables
Sector: Consumer Discretionary
Current Symbol: FKRAF
Website: fiskarsgroup.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.39
Quick Ratio: 0.65

Price-to-Earnings

Trailing P/E Ratio: 46.18
Forward P/E Ratio: 0

FKRAF Technical Analysis vs Fundamental Analysis

Buy
60
Fiskars Oyj (FKRAF) is a Buy

Is Fiskars Oyj a Buy or a Sell?

  • Fiskars Oyj stock is rated a Buy
    The current Fiskars Oyj [FKRAF] share price is $16.50. The Score for FKRAF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.